早期乳腺癌前哨淋巴结活检阳性情况下腋窝的优化管理
Towards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancer.
作者信息
Wazir Umar, Manson Aisling, Mokbel Kefah
机构信息
Umar Wazir, Aisling Manson, Kefah Mokbel, The London Breast Institute, Princess Grace Hospital, London W1U 5NY, United Kingdom.
出版信息
World J Clin Oncol. 2014 Dec 10;5(5):792-4. doi: 10.5306/wjco.v5.i5.792.
Abstract
The sentinel lymph node biopsy (SLNB) was initially pioneered for staging melanoma in 1994 and it has been subsequently validated by several trials, and has become the new standard of care for patients with clinically node negative invasive breast cancer. The focussed examination of fewer lymph nodes in addition to improvements in histopathological and molecular analysis has increased the rate at which micrometastases and isolated tumour cells are identified. In this article we review the literature regarding the optimal management of the axilla when the SLNB is positive for metastatic disease based on level 1 evidence derived from randomised clinical trials.
摘要
前哨淋巴结活检（SLNB）最初于1994年被用于黑色素瘤分期，随后经过多项试验验证，已成为临床腋窝淋巴结阴性浸润性乳腺癌患者的新治疗标准。除了在组织病理学和分子分析方面有所改进外，对较少淋巴结的重点检查提高了微转移和孤立肿瘤细胞的检出率。在本文中，我们基于随机临床试验得出的一级证据，回顾了有关前哨淋巴结活检转移性疾病呈阳性时腋窝最佳管理的文献。
相似文献
1
Towards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancer.
World J Clin Oncol. 2014 Dec 10;5(5):792-4. doi: 10.5306/wjco.v5.i5.792.
2
Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice.
In Vivo. 2018 Nov-Dec;32(6):1301-1307. doi: 10.21873/invivo.11380.
3
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
4
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Dan Med J. 2012 Jul;59(7):B4475.
5
Preoperative Ultrasound-guided Core Biopsy of Axillary Nodes for Staging of Clinically Negative Axilla in Breast Cancer Patients - A Pilot Study.
Cureus. 2020 Jan 21;12(1):e6718. doi: 10.7759/cureus.6718.
6
The evolution of the sentinel node procedure in the treatment of breast cancer.
Dan Med J. 2017 Oct;64(10).
7
Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Arch Gynecol Obstet. 2018 Jun;297(6):1509-1515. doi: 10.1007/s00404-018-4760-2. Epub 2018 Mar 29.
8
9
Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Chir Ital. 2007 Sep-Oct;59(5):693-9.
10
Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
BMC Surg. 2015 Jun 30;15:79. doi: 10.1186/s12893-015-0067-4.
引用本文的文献
1
Reevaluating Axillary Lymph Node Dissection in Total Mastectomy for Low Axillary Burden Breast Cancer: Insights from a Meta-Analysis including the SINODAR-ONE Trial.
Cancers (Basel). 2024 Feb 10;16(4):742. doi: 10.3390/cancers16040742.
2
Thematic trends and knowledge structure map of sentinel lymph node biopsy for breast cancer: a bibliometric analysis from 2010 to 2019.
Transl Cancer Res. 2022 Sep;11(9):3092-3107. doi: 10.21037/tcr-21-2841.
本文引用的文献
1
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol. 2014 May 1;32(13):1365-83. doi: 10.1200/JCO.2013.54.1177. Epub 2014 Mar 24.
2
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.
Breast Cancer Res Treat. 2014 Feb;144(1):71-7. doi: 10.1007/s10549-014-2856-3. Epub 2014 Feb 6.
3
The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
Eur J Surg Oncol. 2014 Feb;40(2):150-7. doi: 10.1016/j.ejso.2013.12.007. Epub 2013 Dec 18.
4
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11.
5
Sentinel lymph node micrometastasis in human breast cancer: an update.
Surg Oncol. 2011 Dec;20(4):e195-206. doi: 10.1016/j.suronc.2011.06.006. Epub 2011 Jul 23.
6
Clinical significance of sentinel lymph node isolated tumour cells in breast cancer.
Breast Cancer Res Treat. 2011 Jun;127(2):325-34. doi: 10.1007/s10549-011-1476-4. Epub 2011 Apr 1.
7
The clinical significance of sentinel lymph node micrometastasis in breast cancer.
Breast Cancer Res Treat. 2009 Apr;114(3):393-402. doi: 10.1007/s10549-008-0021-6. Epub 2008 Apr 20.
8
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.
Lancet Oncol. 2006 Dec;7(12):983-90. doi: 10.1016/S1470-2045(06)70947-0.
9
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
Ann Surg. 2005 Oct;242(4):593-9; discussion 599-602. doi: 10.1097/01.sla.0000184210.68646.77.
10
Revision of breast cancer staging: the 6th edition of the TNM Classification.
Semin Surg Oncol. 2003;21(1):53-9. doi: 10.1002/ssu.10021.
Zotero 插件